Cathepsin B Nuclear Flux in a DNA-Guided "Antinuclear Missile" Cancer Therapy

Area of Science:

• Immunology
• Oncology
• Molecular Biology

Background:

• Antinuclear antibodies (ANAs) can interact with extracellular nucleic acids in the tumor microenvironment.
• These nucleic acids are internalized by live cancer cells via nucleoside salvage pathways, independent of surface antigens.

Purpose of the Study:

• To investigate the mechanism of ANA nuclear penetration and its consequences.
• To develop a novel antibody-drug conjugate (ANADC) for cancer therapy leveraging this mechanism.

Main Methods:

• Studied ANA nuclear entry and its effect on nuclear integrity.
• Designed an ANADC utilizing a cathepsin B-labile linker.
• Evaluated the ANADC's targeting of nucleic acid debris from necrotic tumors.

Main Results:

• ANA nuclear penetration was shown to induce nuclear flux mediated by cathepsin B.
• The ANADC successfully targeted extracellular nucleic acids and entered cancer cells.
• The ANADC demonstrated potential as a tumor-agnostic therapeutic approach.

Conclusions:

• ANA nuclear penetration is a viable mechanism for delivering payloads into cancer cells.
• ANADCs represent a promising new class of cancer therapeutics.
• This approach offers a tumor-agnostic strategy for targeting cancer through nucleic acid salvage pathways.